The stock's fall snapped a two-day winning streak.

Boston Scientific has led a $175 million funding round for the mitral valve developer 4C Medical, which is currently working ...

Boston Scientific stock (NYSE: BSX) has gained 3% in the five days since its Q4 earnings report last week. Although the company exceeded expectations with both its results and guidance ...

Boston Scientific has reached an agreement to acquire SoniVie, a medical device company developing the TIVUS Intravascular Ultrasound System, an investigational technology aimed at treating ...

In the closing of the recent trading day, Boston Scientific (BSX) stood at $95.52, denoting a +1.48% change from the preceding trading day. Boston Scientific (NYSE:BSX) recently experienced a 4% ...

The curtain has come down on one of the most successful charity partnerships ever seen in the city – but its legacy will live ...

Shares of Boston Scientific Corp. BSX slipped 1.66% to $99.13 Friday, on what proved to be an all-around great trading ...